The purpose of the present study is to evaluate in hemodialysis patients, who have elevated serum ferritin ( \>2000ng/ml) and transferrin saturation (TSAT) \>30%, iron deposition in the heart, pancreas, liver and spleen using the T2\* MRI technique. In addition, we will also measure the free iron forms in the plasma and LPI, LCI in red blood cells, platelets and PMN, in addition to serum hepcidin, TSAT, serum ferritin, CRP and oxidative stress parameters (ROS,GSH, and malonyldialdehyde (MDA).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
T2*MRI (magnetic resonance imaging)
Timeframe: one year